Three newer migraine drugs were included in the analysis: lasmiditan (Reyvow), rimegepant (Nurtec), and ubrogepant (Ubrelvy).

Triptans are the most likely class of drug to relieve migraines, yet only a fifth of patients are prescribed the medicine ...

The comparative efficacy and tolerability of oral migraine medications suggest four triptans are superior to the newer, more ...

A meta-analysis of 137 clinical trials finds triptan drugs are among the most effective for treating migraines, while newer ditan and gepant drugs were rated less highly ...

The most effective medicine for migraines has been revealed in a comprehensive analysis by Oxford University researchers - ...

Some triptans are a more effective treatment for acute migraines than newer, more expensive drugs, finds an analysis of the ...

Oxford University scientists reviewed 89,000 patients in clinical trials given 17 different pills for migraine attacks and ...

Some triptans are a more effective treatment for acute migraines than newer, more expensive drugs, finds an analysis of the ...

10 mg OD tablets 5 or 10 mg p.o.; can be repeated after 2 h (max 30 mg/day) Sumatriptan – Imitrex® 25, 50, 100 mg tablets 5, 20 mg nasal spray, 4, 6 mg/0.5 ml cartridges; 6 mg/0.5 ml vials 50 ...

The analysis, published in The British Medical Journal, showed that eletriptan, rizatriptan, sumatriptan, and zolmitriptan ...

‘Comparative effects of drug interventions for the acute management of migraine episodes in adults: systematic review and network meta-analysis’ by William K Karlsson et al. was published in The BMJ ...

Tonix's priority is to submit a New Drug Application (“NDA”) to the FDA in the second ... Tonix Medicines, the company's commercial subsidiary, markets Zembrace(R) SymTouch(R) (sumatriptan injection) ...